Reactive Robotics wins funding to develop physical therapy robot
German firm Reactive Robotics has secured significant funding in a round led by new investor Dr Doll Holding and featuring participation from existing backers MTIP MedTech Innovation Partners, High-Tech Gründerfonds, Bayern Kapital and TQ-Group. Reactive Robotics provides very early mobilisation (VEM) therapy to intensive care patients and is developing an intelligent physical and occupational therapy robotic device that will replace manual VEM therapy. The new funds will be used to expand at home and abroad.

Munich-based company Reactive Robotics GmbH secured a second seven-digit funding round to continue its work in rehabilitation robotics development.

Investors included new lead investor Dr. Doll Holding GmbH and existing investors MTIP MedTech Innovation Partners AG, High-Tech Gründerfonds, Bayern Kapital and TQ-Group.

Reactive Robotics intends to use the funds to further market entry in Germany as well as in other countries.

CEO Dr. Alexander Koenig founded the company in 2015 to provide quality Very Early Mobilization, which improves patient recovery times, to intensive care patients in their beds within 24 hours of their hospital admission.

The team is working on an intelligent therapy device that replaces the manual VEM therapy with a robotic option. The solution would help critically ill patients recover quicker, reduce the work and strain on caretakers and would bring the therapy directly to patients instead of requiring them to go to therapy.

So far the company has developed a prototype, established a quality management system and cooperated with business partners and suppliers.

Previously, the company was able to secure approximately $1.5 million in funding.